{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:14Z","timestamp":1792686434668,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pop.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T21:00:10Z","timestamp":1526072410000},"page":"305-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Primary Care Vasculitis"],"prefix":"10.1016","volume":"45","author":[{"given":"Mathilde H.","family":"Pioro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.1780370411","article-title":"HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis","volume":"37","author":"Weyand","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sarh.2002.50025","article-title":"Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica","volume":"33","author":"Gonzalez-Gay","year":"2003","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pop.2018.02.007_bib5","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/art.34647","article-title":"Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.pop.2018.02.007_bib7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2006.051979","article-title":"Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"65","author":"Cutolo","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/03009740500474586","article-title":"Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls","volume":"35","author":"Demir","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W","article-title":"Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study","volume":"41","author":"Salvarani","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.1780390110","article-title":"Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report on nineteen cases","volume":"39","author":"Salvarani","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.21067","article-title":"Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color Doppler ultrasound, and magnetic resonance imaging findings","volume":"53","author":"Klauser","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10067-004-1061-x","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: ultrasonography as a diagnostic tool","volume":"24","author":"Agarwal","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2000.8366","article-title":"Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study","volume":"30","author":"Cantini","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/art.1780390220","article-title":"Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate","volume":"39","author":"Helfgott","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.1997.00440240081012","article-title":"Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome","volume":"157","author":"Gonzalez-Gay","year":"1997","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.pop.2018.02.007_bib17","first-page":"1333","article-title":"Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis","volume":"26","author":"Proven","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"6361","key":"10.1016\/j.pop.2018.02.007_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","article-title":"Simple rule for calculating normal erythrocyte sedimentation rate","volume":"286","author":"Miller","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"11","key":"10.1016\/j.pop.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/35.11.1161","article-title":"A\u00a0prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis","volume":"35","author":"Myklebust","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"10","key":"10.1016\/j.pop.2018.02.007_bib20","first-page":"2351","article-title":"The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration","volume":"27","author":"Wener","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.pop.2018.02.007_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pop.2018.02.007_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.23.6.447","article-title":"Polymyalgia rheumatica: biopsy studies","volume":"23","author":"Gordon","year":"1964","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.pop.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib24","first-page":"1049","article-title":"Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study","volume":"28","author":"Cantini","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib25","first-page":"462","article-title":"Inflammatory changes of hip synovial structures in polymyalgia rheumatica","volume":"23","author":"Cantini","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3899\/jrheum.130946","article-title":"Joint involvement in patients with early polymyalgia rheumatica using high-resolution ultrasound and its contribution to the EULAR\/ACR 2012 classification criteria for polymyalgia rheumatica","volume":"41","author":"Weigand","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.pop.2018.02.007_bib30","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.39333","article-title":"2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"67","author":"Dejaco","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"10.1016\/j.pop.2018.02.007_bib31","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","article-title":"Treatment of polymyalgia rheumatica: a systematic review","volume":"169","author":"Hernandez-Rodriguez","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/37.2.189","article-title":"An initially double-blind controlled 96\u00a0week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica","volume":"37","author":"Dasgupta","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"10","key":"10.1016\/j.pop.2018.02.007_bib33","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9343(85)90309-2","article-title":"Polymyalgia rheumatica. Duration of therapy and long-term outcome","volume":"79","author":"Ayoub","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib36","first-page":"395","article-title":"Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids","volume":"26","author":"Cimmino","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib37","first-page":"65","article-title":"Relapse in a population based cohort of patients with polymyalgia rheumatica","volume":"32","author":"Kremers","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0950-3579(05)80063-9","article-title":"Clinical features of giant cell arteritis","volume":"5","author":"Jones","year":"1991","journal-title":"Baillieres Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/39.3.283","article-title":"The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis: a prospective study of 231 cases","volume":"39","author":"Gran","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib40","first-page":"115","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis?","volume":"26","author":"Sibilia","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3899\/jrheum.110558","article-title":"Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica","volume":"39","author":"Kimura","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semarthrit.2008.11.006","article-title":"Is remitting seronegative symmetrical synovitis with pitting edema (RS3PE) a subset of rheumatoid arthritis?","volume":"40","author":"Yao","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib43","first-page":"404","article-title":"RS3PE revisited: a systematic review and meta-analysis of 331 cases","volume":"34","author":"Karmacharya","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib47","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2009.111005","article-title":"Increase in age at onset of giant cell arteritis: a population-based study","volume":"69","author":"Kermani","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.pop.2018.02.007_bib48","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.pop.2018.02.007_bib50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pop.2018.02.007_bib51","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10-year study","volume":"26","author":"Gonzalez-Gay","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pop.2018.02.007_bib56","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/art.1780241113","article-title":"Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin","volume":"24","author":"Calamia","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pop.2018.02.007_bib57","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1532-5415.1993.tb07301.x","article-title":"Fever of unknown origin in elderly patients","volume":"41","author":"Knockaert","year":"1993","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study","volume":"45","author":"Salvarani","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib60","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ophtha.2005.01.031","article-title":"Management of the patient with suspected temporal arteritis a decision-analytic approach","volume":"112","author":"Niederkohr","year":"2005","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.pop.2018.02.007_bib61","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-120-12-199406150-00003","article-title":"How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?","volume":"120","author":"Achkar","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12891-016-1225-2","article-title":"The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis","volume":"17","author":"Jakobsson","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","article-title":"Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis","volume":"37","author":"Narvaez","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib65","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography","volume":"71","author":"Prieto-Gonzalez","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.pop.2018.02.007_bib66","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/kes153","article-title":"Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis","volume":"51","author":"Hauenstein","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-142-5-200503010-00011","article-title":"Meta-analysis: test performance of ultrasonography for giant-cell arteritis","volume":"142","author":"Karassa","year":"2005","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib68","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","article-title":"Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study","volume":"73","author":"Prieto-Gonzalez","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pop.2018.02.007_bib69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2011.09.007","article-title":"AL amyloidosis with temporal artery involvement simulates giant-cell arteritis","volume":"79","author":"Audemard","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib70","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.pop.2018.02.007_bib71","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pop.2018.02.007_bib73","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3899\/jrheum.121150","article-title":"Statin use in giant cell arteritis: a retrospective study","volume":"40","author":"Schmidt","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib74","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib75","first-page":"495","article-title":"A\u00a0prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.pop.2018.02.007_bib76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib77","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A\u00a0double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.pop.2018.02.007_bib78","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10031","key":"10.1016\/j.pop.2018.02.007_bib79","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib80","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pop.2018.02.007_bib81","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/acr.20435","article-title":"Pneumocystis jiroveci pneumonia in giant cell arteritis: a case series","volume":"63","author":"Kermani","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.pop.2018.02.007_bib82","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"10.1016\/j.pop.2018.02.007_bib84","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib85","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3899\/jrheum.141347","article-title":"Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study","volume":"42","author":"Kermani","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.pop.2018.02.007_bib86","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2012-202145","article-title":"Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis","volume":"73","author":"Mackie","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.pop.2018.02.007_bib88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/annrheumdis-2013-204113","article-title":"The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454318300125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454318300125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T15:01:45Z","timestamp":1534863705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454318300125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0095454318300125"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2018.02.007","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Care Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}